Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Lack of trading volume allows the share price to drift down

<< Previous

Bullboard Posts

Next >>

Comment by Ticklel1ston May 05, 2021 11:16am

124 Views

Post# 33131960

RE:RE:RE:RE:Lack of trading volume allows the share price to drift down

You guys are truely laughable. This is the patern that has gone on for years. Spin it as a great buying opportunity...too funny.

Wake up and call this what it is...failure after failure by management to get anything worth while done...except pay them selves really well for being part time vancouver pigs.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management